Hyperstability

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Retrieved on: 
Monday, August 8, 2022

FREEHOLD, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new publication featuring the Company’s QTY protein code technology in Chemical Reviews, a top-ranked peer-reviewed scientific journal and the official journal of American Chemical Society (journal Impact Factor is 72). The publication, entitled “Protein Design: From the Aspect of Water Solubility and Stability,” focuses on the innovative QTY protein design code—co-developed by Avalon—as a novel platform to generate water-soluble proteins for a wide spectrum of biomedical applications. The Company initially licensed the technology from the Massachusetts Institute of Technology (MIT) and has advanced the platform through a sponsored research agreement with the university.

Key Points: 
  • FREEHOLD, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new publication featuring the Companys QTY protein code technology in Chemical Reviews, a top-ranked peer-reviewed scientific journal and the official journal of American Chemical Society (journal Impact Factor is 72).
  • The Company initially licensed the technology from the Massachusetts Institute of Technology (MIT) and has advanced the platform through a sponsored research agreement with the university.
  • The publication provides a comprehensive review of the QTY protein code design platform.
  • Our QTY protein design code extends this knowledge, enabling an even more precise understanding and manipulation of protein structures and function.